CRONOS GROUP INC. (CRON) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 56.36M USD | Liabilities, Current |
| Cash and equivalents | 467.02M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 36.72M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | 52.70M USD | Inventory, Net |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $56.36M | $467.02M | (m) | $36.72M | $52.70M | (m) |
| 2026-03-31 | (m) | $42.42M | $821.86M | (m) | $32.96M | $48.68M | (m) |
| 2025-12-31 | (m) | $48.19M | $791.79M | (m) | $34.10M | $46.75M | (m) |
| 2025-09-30 | (m) | $41.07M | $784.17M | (m) | $27.09M | $48.17M | (m) |
| 2025-06-30 | (m) | $37.61M | $794.42M | (m) | $26.62M | $42.14M | (m) |
| 2025-03-31 | (m) | $33.05M | $797.82M | (m) | $18.71M | $34.60M | (m) |
| 2024-12-31 | (m) | $49.70M | $858.80M | (m) | $15.46M | $33.15M | (m) |
| 2024-09-30 | (m) | $39.56M | $862.03M | (m) | $20.48M | $47.25M | (m) |
| 2024-06-30 | (m) | $33.06M | $848.19M | (m) | $16.18M | $29.18M | (m) |
| 2024-03-31 | (m) | $33.42M | $855.11M | (m) | $15.34M | $30.64M | (m) |
| 2023-12-31 | (m) | $41.40M | $669.29M | (m) | $13.98M | $30.50M | (m) |
| 2023-09-30 | (m) | $30.58M | $571.66M | (m) | $15.73M | $35.85M | (m) |
| 2023-06-30 | (m) | $27.93M | $409.43M | (m) | $12.54M | $45.19M | (m) |
| 2023-03-31 | (m) | $29.13M | $413.67M | (m) | $14.86M | $44.27M | (m) |
| 2022-12-31 | (m) | $68.12M | $764.64M | (m) | $23.11M | $37.56M | (m) |
| 2022-09-30 | (m) | $37.97M | $633.30M | (m) | $19.09M | $34.09M | (m) |
| 2022-06-30 | (m) | $39.20M | $789.54M | (m) | $19.38M | $39.84M | (m) |
| 2022-03-31 | (m) | $40.25M | $861.53M | (m) | $25.81M | $37.05M | (m) |
| 2021-12-31 | (m) | $54.37M | $886.97M | (m) | $22.07M | $32.80M | (m) |
| 2021-09-30 | (m) | $69.60M | $842.57M | (m) | $14.67M | $31.77M | (m) |
| 2021-06-30 | (m) | $200.60M | $895.18M | (m) | $11.30M | $35.60M | (m) |
| 2021-03-31 | (m) | $302.64M | $1.02B | (m) | $7.00M | $46.44M | (m) |
| 2020-12-31 | (m) | $206.83M | $1.08B | (m) | $8.93M | $44.00M | (m) |
| 2020-09-30 | (m) | $142.94M | $1.10B | (m) | $6.09M | $56.36M | (m) |
| 2020-06-30 | (m) | $235.24M | $1.11B | (m) | $3.48M | $53.22M | (m) |
| 2020-03-31 | (m) | $201.52M | $1.13B | (m) | $3.40M | $43.12M | (m) |
| 2019-12-31 | (m) | $332.89M | $1.20B | (m) | $4.64M | $38.04M | (m) |
| 2018-12-31 | (m) | $33.27M | $23.93M | (m) | $3.05M | $7.39M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |